A Report Upon a Cohort of Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy for Hormone-dependant Breast Cancer. Long-term Tolerance Evaluation
N/A
N/A
N/A
N/A
N/A
Not Enrolling
Female
Breast Cancer
Female
Breast Cancer
Trial Information
A Report Upon a Cohort of Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy for Hormone-dependant Breast Cancer. Long-term Tolerance Evaluation
Inclusion Criteria:
- woman treated with anastrozole as adjuvant therapy for hormone-dependant breast
cancer in post-menopausal women with positive hormone-receptors
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
AstraZeneca France Medical Director
Investigator Role:
Study Director
Investigator Affiliation:
AstraZeneca
Authority:
France: Conseil National de l'Ordre des Médecins
Study ID:
NIS-OFR-ARI-2005/1
NCT ID:
NCT00542594
Start Date:
November 2005
Completion Date:
June 2011
Related Keywords:
- Breast Cancer
- breast cancer
- anastrozole
- Breast Neoplasms
Name | Location |
|---|
